Journal of Blood Medicine
Overview
Journal of Blood Medicine is a scientific journal, published by Dove Medical Press since 2010 in English. The journal's country of origin is New Zealand and its primary focus area is hematology.
Details
Details
Abbr.
J Blood Med
Publisher
Dove Medical Press
Start
2010
End
Continuing
e-ISSN
1179-2736
Country
New Zealand
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 10816
28
SJR / Ranks: 8430
534
CiteScore / Ranks: 8368
3.10
Recent Articles
1.
Huang B, Sun J, Yu L, Xiong J
J Blood Med
. 2025 Feb;
16:83-93.
PMID: 40007580
Background: The use of blood transfusion in surgery is increasing, and the blood supply is getting tighter. The number of glioma surgeries is increasing year by year, and reports of...
2.
Lewandowska M, Nasr S, Shapiro A
J Blood Med
. 2025 Feb;
16:95-115.
PMID: 39995897
In recent years, gene therapy and bio-engineered hemostatic molecules have revolutionized treatment for people with hemophilia. These innovative therapies aim to decrease treatment burden and improve patient quality of life....
3.
Putriana N, Rusdiana T, Rostinawati T, Latarissa I
J Blood Med
. 2025 Feb;
16:75-82.
PMID: 39991637
Introductions: Spinach () is a green vegetable containing 380 μg/100 g of vitamin K, while warfarin serves as an antagonist in inhibiting vitamin K epoxide reductase subunit C1 (VKORC). In...
4.
Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B, et al.
J Blood Med
. 2025 Feb;
16:61-74.
PMID: 39926111
Purpose: This study aimed to compare platelet count, platelet indices, lymphocyte, and systemic inflammation indices between surviving and non-surviving COVID-19 patients, measured at admission and on the eighth day of...
5.
Hantrakool S, Sriwichai M, Shaengkhamnang B, Leetrakool N, Niprapan P, Kawichai S, et al.
J Blood Med
. 2025 Feb;
16:51-60.
PMID: 39911405
Aim: Exposure to fine particulate matter, particularly PM2.5, has been associated with increased platelet activation and cardiovascular risks. However, its effect on platelet recovery after transfusion remains unclear. Purpose: This...
6.
Yovera-Ancajima C, Calderon Cumpa L, Lezama-Cotrina I, Walttuoni-Picon E, Cardenas-Mendoza W, Culqui-Garcia J, et al.
J Blood Med
. 2025 Feb;
16:41-49.
PMID: 39902094
Background: Red blood cell alloimmunization currently continues to be a significant problem during the blood transfusion process, where phenotypic identification plays a clinically relevant role in its prevention. The objective...
7.
Mizoguchi Y, Hino M, Ueda H, Miyaguchi Y, Kobayashi M
J Blood Med
. 2025 Jan;
16():27-39.
PMID: 39811825
Purpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. However, interindividual differences affect the half-life and clearance of rFVIII products. The myPKFiT is a...
8.
He C, Ma H, Zhang T, Liu Y, Zhang C, Deng S
J Blood Med
. 2025 Jan;
16():15-25.
PMID: 39802915
Purpose: To study the platelet adhesion and aggregation behaviour of late pregnancy women under arterial shear rate using microfluidic chip technology and evaluate the risk of thrombosis in late pregnancy....
9.
Memon H, Parrondo R, Schreurs J, Ayala E, Iqbal M
J Blood Med
. 2025 Jan;
16():7-13.
PMID: 39802914
Systemic sclerosis (SSc) is a multi-system disease characterized by a dysregulated immune system. Autologous hematopoietic cell transplantation (AHCT) is the only treatment that has been shown to confer significant benefit...
10.
Ajdacic-Gross V, Buadze A, Wagner E, Muller M, Seifritz E, Ranjbar S, et al.
J Blood Med
. 2025 Jan;
16():1-5.
PMID: 39781374
Previous research has unveiled an intriguing positive association between the AB blood group and mental disorders in general. In this study, we compared ABO blood groups with five major groups...